American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

January 07, 2022

Newsletter Sponsor

Your Global Equipment and Processing Solution

A global full service company founded in 1972, Freund-Vector Corporation designs, manufactures processing equipment and services for the processing of powders, particles, beads, pellets, tablets and other solid materials/forms to the pharmaceutical, nutritional, food, confectionery, chemical, powdered metals, cannabis, automotive and pyrotechnics industries. Equipment applications include coating, drying, agglomerating, granulating, layering, pelletizing, densification and tablet forming.

	Industry News

FDA Grants Breakthrough Designation for New Treatment for Patients with Non-Small Cell Lung Cancer
Cullinan Oncology announced that the FDA has granted Breakthrough Therapy Designation for CLN-081 ... read more »

Novartis Announces U.S. Court of Appeals for the Federal Circuit (CAFC) Upholds Validity of Gilenya® (Fingolimod) Dosage Regimen Patent
Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its decision... read more »

Novo Holdings to Acquire Ritedose
Founded in 1995 and headquartered in Columbia, S.C., The Ritedose Corporation is a sterile ... read more »

Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA
Biogen Inc. and Ionis Pharmaceuticals, Inc. announced that Biogen exercised its option to obtain ... read more »

	Infographic

Make the Switch to Automated At-line Testing for Mycoplasma: Four compelling reasons to upgrade now
Make the Switch to Automated At-line Testing for Mycoplasma
Fully automated PCR systems have been introduced into the market and offer several improvements over traditional PCR-based methods and can be used to ... read more »

	Featured Articles

Improving Preclinical Outcomes: De-Risking Your Drug Development Program Introducing a new drug candidate to market is a complex and time-intensive process that can cost pharmaceutical companies $1 billion and more than a ... read more »

Modern Perspectives on LAL Non-Endotoxin Reactivity Take a minute to look outside. Hopefully you see some trees, grass, and dead leaves in the fall. What you likely don’t see but is everywhere as well ... read more »

	Featured Video

On-Demand Webinar: Unified Particle Analysis by Raman and Infrared Microscopy
In this webinar you’ll learn: Identification of unknown particles in a wide variety of manufacturing processes. Reverse engineering and failure ... watch »

On-Demand Webinar: Validation of a Mycoplasma NAT Platform for Product Release in Cell Therapy
This webinar will provide a review of validation strategies and implementation for a rapid at-line mycoplasma test for cell therapy companies. watch »

	Featured Products

Eshmuno® CMX Chromatography Resin
read more »

	Featured Whitepaper

Whitepaper: Tabletability, Compactability, and Compressibility: What's the Difference?
To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. That's where ... read more »

	Events

SMi’s 10th Annual Pharmaceutical Microbiology UK Conference
Online – 01/17/2022
Exploring Robust Risk-Based Microbiological Control Strategy SMi’s flagship microbiology conference is celebrating its 10-year anniversary. The ... event details »

DCAT Sharp Sourcing
Online – 01/26/2022
This 90-minute webinar brings together a panel of industry experts to offer valuable and practical insights into what companies need to consider and ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA